Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026; Astellas Pharma Inc., Athersys Inc., among others, emerge as key vendors

/PRNewswire/ -- The cell therapy market size is forecasted to increase by USD 21.061 billion from 2021 to 2026, at a CAGR of 56.79%, according to the recent...

Related Keywords

United States ,China ,United Kingdom ,Germany ,Vietnam ,Republic Of ,India ,Malaysia ,Japan ,America ,Jesse Maida ,Bristol Myers Squibb ,Astellas Pharma Inc ,Avita Medical Inc ,Thermogenesis Holdings Inc ,Product Service ,Cellular Biomedicine Group Inc ,Health Care Market ,Technavio Research ,Brainstorm Cell Therapeutics Inc ,Amgen ,Bristol Myers Squibb Co ,Capricor Therapeutics Inc ,Athersys Inc ,Sanpower Group Co ,Gilead Sciences Inc ,Vericel Corp ,Castle Creek Biosciences Inc ,Mesoblast Ltd ,Biocardia Inc ,Lineage Cell Therapeutics Inc ,Caladrius Biosciences Inc ,Cellseed Inc ,Pharmicell Co ,Industry Players ,North America ,B Cell Non Hodgkin ,South America ,Market Positioning ,Competitive Strategies ,Pharma Inc ,Bone Therapeutics ,Celyad Oncology ,Sanpower Group ,Executive Summary ,Data Table ,Global Market ,Market Segmentation ,Vendor Market ,Astellas Pharma ,Myers Squibb ,Creek Biosciences ,Castle Creek Biosciences ,Gilead Sciences ,Technavio ,